We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$11.1B
AUM Growth
+$2.91B
Cap. Flow
+$2.44B
Cap. Flow %
22.01%
Top 10 Hldgs %
80.14%
Holding
1,432
New
428
Increased
273
Reduced
246
Closed
471

Sector Composition

Rank Sector Weight
1 Technology 2.19%
2 Financials 1.49%
3 Industrials 1.31%
4 Consumer Discretionary 0.86%
5 Energy 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
976
American International
AIG
$40.7B
-7,573
Closed -$513K
AIN icon
977
Albany International
AIN
$1.73B
-2,081
Closed -$204K
AIV
978
Aimco
AIV
$377M
-24,769
Closed -$194K
AJG icon
979
Arthur J. Gallagher & Co
AJG
$64.7B
-1,562
Closed -$351K
AKAM icon
980
Akamai
AKAM
$16.9B
-6,672
Closed -$790K
AL
981
DELISTED
Air Lease Corp
AL
-22,327
Closed -$936K
ALB icon
982
Albemarle
ALB
$15.5B
-7,223
Closed -$1.04M
ALE
983
DELISTED
Allete
ALE
-6,505
Closed -$398K
ALEC icon
984
Alector
ALEC
$189M
-18,975
Closed -$151K
ALGM icon
985
Allegro MicroSystems
ALGM
$7.91B
-17,388
Closed -$526K
ALGN icon
986
Align Technology
ALGN
$12.5B
-2,318
Closed -$635K
AMED
987
DELISTED
Amedisys
AMED
-3,228
Closed -$307K
AMGN icon
988
Amgen
AMGN
$226B
-922
Closed -$266K
AMH icon
989
American Homes 4 Rent
AMH
$12.3B
-69,164
Closed -$2.49M
AMLX icon
990
Amylyx Pharmaceuticals
AMLX
$2.53B
-53,517
Closed -$788K
AMR icon
991
Alpha Metallurgical Resources
AMR
$1.95B
-694
Closed -$235K
ANAB icon
992
AnaptysBio
ANAB
$1.64B
-9,673
Closed -$207K
ANGO icon
993
AngioDynamics
ANGO
$651M
-19,048
Closed -$149K
AON icon
994
Aon
AON
$75.7B
-1,293
Closed -$376K
APA icon
995
APA Corp
APA
$14.4B
-11,344
Closed -$407K
APPN icon
996
Appian
APPN
$2.55B
-6,963
Closed -$262K
APTV icon
997
Aptiv
APTV
$10.3B
-2,519
Closed -$226K
ARCT icon
998
Arcturus Therapeutics
ARCT
$200M
-6,749
Closed -$213K
ARMK icon
999
Aramark
ARMK
$14.6B
-19,317
Closed -$543K
ARQT icon
1000
Arcutis Biotherapeutics
ARQT
$3.26B
-51,442
Closed -$166K

Similar funds

Brevan Howard Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Brevan Howard Capital Management held 1,432 positions worth $11.1B, up 36% from $8.18B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Brevan Howard Capital Management deployed $2.44B of net new capital in Q1 2024, opening 428 new positions and adding to 273 existing holdings. Its largest new stake was CME Group: 102,553 shares worth $22.1M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 1.7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $14.9M trimmed.

  • Brevan Howard Capital Management's largest Q1 2024 buy was CME Group: 102,553 shares worth $22.1M.
  • Brevan Howard Capital Management added most to Workday in Q1 2024, an estimated $31.9M increase.
  • Brevan Howard Capital Management's biggest Q1 2024 reduction was Home Depot, cutting an estimated $14.9M.
  • Brevan Howard Capital Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $111M.
  • Brevan Howard Capital Management's ten largest holdings make up 80% of its $11.1B portfolio in Q1 2024.
  • Brevan Howard Capital Management opened 428 new positions and closed 471 in Q1 2024.
  • Brevan Howard Capital Management's portfolio value rose 36% quarter-over-quarter to $11.1B.

Based on Brevan Howard Capital Management's 13F filing for Q1 2024, filed 15 May 2024.